Cytokinetics Presents New Data From REDWOOD-HCM OLE in
Treatment with Aficamten Associated with Significant Improvements in Symptoms and Quality of Life Additional Data Presented in Poster Session Shows...
Source: globenewswire.com
Stay updated with breaking news from Circ Heart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Treatment with Aficamten Associated with Significant Improvements in Symptoms and Quality of Life Additional Data Presented in Poster Session Shows...
SOUTH SAN FRANCISCO, Calif., May 17, 2022 -- Cytokinetics, Incorporated today announced the Company recently participated in a mid-cycle communication meeting with the U.S. Food & Drug... | May 17, 2022
No Effect of Omecamtiv Mecarbil On Exercise Capacity in Patients with Heart Failure with Reduced Ejection Fraction Results Will Be Presented in Late Breaking Clinical Trial Session at the American... | February 15, 2022